CTH-004

N/A

Report date: 2025/05/09 11:22:13

Base Information

Drug NameCTH-004

Drug Alias NameCTH-004

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionTumor-associated glycoprotein 72 inhibitors

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCartherics Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShunxi Holding Group Co Ltd Cartherics Pty Ltd

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A